Is anticoagulant therapy always indicated in “medium-risk” patients with first diagnosed atrial fibrillation? Insights from a real world, 10-year observational study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Is anticoagulant therapy always indicated in “medium-risk” patients with first diagnosed atrial fibrillation? Insights from a real world, 10-year observational study

Published:2019-08 Issue: Volume:288 Page:76-81
ISSN:0167-5273
Container-title:International Journal of Cardiology
language:en
Short-container-title:International Journal of Cardiology

Author:

Bonfanti Laura,Lippi Giuseppe,Donelli Valentina,Pigna Federica,Saccenti Carlotta,Cervellin Gianfranco

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference33 articles.

1. Stroke prevention in atrial fibrillation: state of the art;Li;Int. J. Cardiol.,2018

2. Risk stratification for stroke in atrial fibrillation: a critique;Killu;Eur. Heart J.,2019

3. 2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS;Kirchhof;Eur. Heart J.,2016

4. Oral anticoagulation, aspirin, or no therapy in patients with nonvalvular AF with 0 or 1 stroke risk factor based on the CHA2DS2-VASc score;Lip;J. Am. Coll. Cardiol.,2015

5. Ischemic stroke risk in patients with atrial fibrillation and CHA2DS2VASc score of 1: systematic review and meta-analysis;Oundi;Stroke,2016

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP